Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1643 | 2558 | 40.4 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
14 | 4 | ORTHOPEDICS//DENTISTRY, ORAL SURGERY & MEDICINE//SPORT SCIENCES | 808941 |
32 | 3 | OSTEOPOROSIS//VITAMIN D//OSTEOPOROSIS INTERNATIONAL | 107093 |
1401 | 2 | BISPHOSPHONATES//ZOLEDRONIC ACID//BONE METASTASES | 8069 |
1643 | 1 | BONE METASTASES//SKELETAL RELATED EVENTS//BONE METASTASIS | 2558 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BONE METASTASES | authKW | 1786852 | 19% | 31% | 479 |
2 | SKELETAL RELATED EVENTS | authKW | 1623674 | 7% | 81% | 167 |
3 | BONE METASTASIS | authKW | 1005162 | 14% | 24% | 347 |
4 | ZOLEDRONIC ACID | authKW | 716325 | 10% | 24% | 247 |
5 | BISPHOSPHONATES | authKW | 606913 | 19% | 10% | 496 |
6 | DENOSUMAB | authKW | 470598 | 6% | 27% | 145 |
7 | METASTATIC BONE DISEASE | authKW | 305900 | 2% | 57% | 45 |
8 | PAMIDRONATE | authKW | 257465 | 4% | 21% | 102 |
9 | IBANDRONATE | authKW | 205238 | 3% | 24% | 71 |
10 | CLODRONATE | authKW | 192639 | 3% | 22% | 72 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 28279 | 54% | 0% | 1384 |
2 | Urology & Nephrology | 2258 | 9% | 0% | 238 |
3 | Health Care Sciences & Services | 987 | 5% | 0% | 118 |
4 | Endocrinology & Metabolism | 968 | 9% | 0% | 221 |
5 | Medicine, General & Internal | 689 | 9% | 0% | 234 |
6 | Rehabilitation | 292 | 3% | 0% | 67 |
7 | Pharmacology & Pharmacy | 170 | 7% | 0% | 191 |
8 | Medicine, Research & Experimental | 60 | 3% | 0% | 78 |
9 | Orthopedics | 55 | 2% | 0% | 49 |
10 | Pathology | 36 | 2% | 0% | 46 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNIT CLIN ONCOL | 126629 | 2% | 21% | 51 |
2 | WESTON PK HOSP | 81276 | 1% | 25% | 27 |
3 | CLIN ENDOCRINOL BONE DIS | 42624 | 0% | 71% | 5 |
4 | SUPPORT CARE CLIN | 38981 | 0% | 47% | 7 |
5 | BONE ONCOL GRP | 35806 | 0% | 100% | 3 |
6 | GRP CELLULAR MACHINES | 35806 | 0% | 100% | 3 |
7 | MULTIPLE MYELOMA BONE METASTASIS PROGRAM | 35806 | 0% | 100% | 3 |
8 | YORKSHIRE CANC CLIN ONCOL | 27120 | 0% | 45% | 5 |
9 | BONE PROGRAM | 24840 | 1% | 14% | 15 |
10 | OSTEONCOL RARE TUMORS | 24629 | 0% | 26% | 8 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF BONE ONCOLOGY | 104227 | 1% | 28% | 31 |
2 | CLINICAL & EXPERIMENTAL METASTASIS | 18681 | 2% | 3% | 56 |
3 | SUPPORTIVE CARE IN CANCER | 10638 | 2% | 1% | 62 |
4 | CANCER TREATMENT REVIEWS | 7907 | 1% | 2% | 36 |
5 | BONE | 7733 | 3% | 1% | 66 |
6 | SEMINARS IN ONCOLOGY | 4780 | 2% | 1% | 46 |
7 | ONCOLOGIST | 4185 | 1% | 1% | 28 |
8 | AUTOMOTIVE PLASTICS | 3977 | 0% | 33% | 1 |
9 | EJC SUPPLEMENTS | 3676 | 0% | 3% | 10 |
10 | REVIEWS IN CONTEMPORARY PHARMACOTHERAPY | 3343 | 0% | 6% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BONE METASTASES | 1786852 | 19% | 31% | 479 | Search BONE+METASTASES | Search BONE+METASTASES |
2 | SKELETAL RELATED EVENTS | 1623674 | 7% | 81% | 167 | Search SKELETAL+RELATED+EVENTS | Search SKELETAL+RELATED+EVENTS |
3 | BONE METASTASIS | 1005162 | 14% | 24% | 347 | Search BONE+METASTASIS | Search BONE+METASTASIS |
4 | ZOLEDRONIC ACID | 716325 | 10% | 24% | 247 | Search ZOLEDRONIC+ACID | Search ZOLEDRONIC+ACID |
5 | BISPHOSPHONATES | 606913 | 19% | 10% | 496 | Search BISPHOSPHONATES | Search BISPHOSPHONATES |
6 | DENOSUMAB | 470598 | 6% | 27% | 145 | Search DENOSUMAB | Search DENOSUMAB |
7 | METASTATIC BONE DISEASE | 305900 | 2% | 57% | 45 | Search METASTATIC+BONE+DISEASE | Search METASTATIC+BONE+DISEASE |
8 | PAMIDRONATE | 257465 | 4% | 21% | 102 | Search PAMIDRONATE | Search PAMIDRONATE |
9 | IBANDRONATE | 205238 | 3% | 24% | 71 | Search IBANDRONATE | Search IBANDRONATE |
10 | CLODRONATE | 192639 | 3% | 22% | 72 | Search CLODRONATE | Search CLODRONATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FORD, J , CUMMINS, E , SHARMA, P , ELDERS, A , STEWART, F , JOHNSTON, R , ROYLE, P , JONES, R , MULATERO, C , TODD, R , ET AL (2013) SYSTEMATIC REVIEW OF THE CLINICAL EFFECTIVENESS AND COST-EFFECTIVENESS, AND ECONOMIC EVALUATION, OF DENOSUMAB FOR THE TREATMENT OF BONE METASTASES FROM SOLID TUMOURS.HEALTH TECHNOLOGY ASSESSMENT. VOL. 17. ISSUE 29. P. 1 -+ | 108 | 74% | 19 |
2 | ROSS, JR , SAUNDERS, Y , EDMONDS, PM , PATEL, S , WONDERLING, D , NORMAND, C , BROADLEY, K , (2004) A SYSTEMATIC REVIEW OF THE ROLE OF BISPHOSPHONATES IN METASTATIC DISEASE.HEALTH TECHNOLOGY ASSESSMENT. VOL. 8. ISSUE 4. P. III-+ | 132 | 65% | 6 |
3 | MACHADO, M , CRUZ, LS , TANNUS, G , FONSECA, M , (2009) EFFICACY OF CLODRONATE, PAMIDRONATE, AND ZOLEDRONATE IN REDUCING MORBIDITY AND MORTALITY IN CANCER PATIENTS WITH BONE METASTASIS: A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS.CLINICAL THERAPEUTICS. VOL. 31. ISSUE 5. P. 962-979 | 65 | 90% | 27 |
4 | ABRAHAMSSON, PA , BODY, JJ , COLEMAN, RE , COLOMER, R , COSTA, L , CRINO, L , DIRIX, L , GNANT, M , GRALOW, J , HADJI, P , ET AL (2008) GUIDANCE ON THE USE OF BISPHOSPHONATES IN SOLID TUMOURS: RECOMMENDATIONS OF AN INTERNATIONAL EXPERT PANEL.ANNALS OF ONCOLOGY. VOL. 19. ISSUE 3. P. 420 -432 | 68 | 60% | 251 |
5 | PORTA-SALES, J , GARZON-RODRIGUEZ, C , LLORENS-TORROME, S , BRUNELLI, C , PIGNI, A , CARACENI, A , (2017) EVIDENCE ON THE ANALGESIC ROLE OF BISPHOSPHONATES AND DENOSUMAB IN THE TREATMENT OF PAIN DUE TO BONE METASTASES: A SYSTEMATIC REVIEW WITHIN THE EUROPEAN ASSOCIATION FOR PALLIATIVE CARE GUIDELINES PROJECT.PALLIATIVE MEDICINE. VOL. 31. ISSUE 1. P. 5 -25 | 57 | 86% | 0 |
6 | FORD, JA , JONES, R , ELDERS, A , MULATERO, C , ROYLE, P , SHARMA, P , STEWART, F , TODD, R , MOWATT, G , (2013) DENOSUMAB FOR TREATMENT OF BONE METASTASES SECONDARY TO SOLID TUMOURS: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS.EUROPEAN JOURNAL OF CANCER. VOL. 49. ISSUE 2. P. 416 -430 | 51 | 84% | 17 |
7 | GOODMAN, R , GLEDHILL, J , FORD, T , (2003) CHILD PSYCHIATRIC DISORDER AND RELATIVE AGE WITHIN SCHOOL YEAR: CROSS SECTIONAL SURVEY OF LARGE POPULATION SAMPLE.BMJ-BRITISH MEDICAL JOURNAL. VOL. 327. ISSUE 7413. P. 472 -475 | 69 | 81% | 38 |
8 | FLEISCH, H , (1991) BISPHOSPHONATES - PHARMACOLOGY AND USE IN THE TREATMENT OF TUMOR-INDUCED HYPERCALCEMIC AND METASTATIC BONE-DISEASE.DRUGS. VOL. 42. ISSUE 6. P. 919-944 | 83 | 62% | 522 |
9 | TOLIA, M , ZYGOGIANNI, A , KOUVARIS, JR , MERISTOUDIS, C , MARGARI, N , KARAKITSOS, P , KOKAKIS, I , KARDAMAKIS, D , PAPADIMITRIOU, C , MYSTAKIDOU, K , ET AL (2014) THE KEY ROLE OF BISPHOSPHONATES IN THE SUPPORTIVE CARE OF CANCER PATIENTS.ANTICANCER RESEARCH. VOL. 34. ISSUE 1A. P. 23 -37 | 77 | 50% | 10 |
10 | RICCARDI, A , GRASSO, D , DANOVA, M , (2003) BISPHOSPHONATES IN ONCOLOGY: PHYSIOPATHOLOGIC BASES AND CLINICAL ACTIVITY.TUMORI. VOL. 89. ISSUE 3. P. 223-236 | 84 | 62% | 7 |
Classes with closest relation at Level 1 |